The cholinergic system in Alzheimer's disease
- 1 August 1997
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 52 (6) , 511-535
- https://doi.org/10.1016/s0301-0082(97)00028-2
Abstract
No abstract availableKeywords
This publication has 217 references indexed in Scilit:
- Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: Implications for cholinergic-based therapiesLife Sciences, 1995
- Muscarinic receptors and novel strategies for the treatment of age-related brain disordersLife Sciences, 1994
- Regional patterns of cholinergic and glutamate activity in the developing and aging human brainDevelopmental Brain Research, 1993
- Diminished muscarinic receptor-stimulated [3H]-PIP2 hydrolysis in alzheimer's diseaseLife Sciences, 1993
- Muscarinic autoreceptors are differentially affected by selective muscarinic antagonists in rat hippocampusNeurochemistry International, 1989
- [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heartLife Sciences, 1987
- Decreased muscarinic receptor binding in cerebral cortex and hippocampus in alzheimer's diseaseLife Sciences, 1987
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983
- [3H] pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortexLife Sciences, 1982
- Acetylcholine and choline levels in post-mortem human brain tissue: Preliminary observations in Alzheimer's diseaseLife Sciences, 1980